Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03508765 · ClinicalTrials.gov registry record · NA
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03508765: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03508765 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03508765, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.
Interventions
- BEHAVIORAL Brief Test of Attention
- DIAGNOSTIC_TEST Structural Image
- DIAGNOSTIC_TEST Functional Image
- BEHAVIORAL Digit Span subtest
- BEHAVIORAL Trail Making Test (Parts A & B)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-03-27 |
| Est. Completion | 2024-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03508765
The ClinicalTrials.gov registry entry for NCT03508765 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Brief Test of Attention is the first listed.
NCT03508765 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03508765 about?
NCT03508765 is a clinical study titled "Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation". The purpose of this study is to learn about possible changes in thinking (cognitive) abilities, such as memory skills, and in brain anatomy and function, in adults with multiple myeloma who are treated with high-dose chemotherapy followed by ASCT.
What is the current status of trial NCT03508765?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-03-27. Estimated completion is 2024-03-06.
What interventions are being tested in trial NCT03508765?
The interventions under investigation include: Brief Test of Attention (BEHAVIORAL), Structural Image (DIAGNOSTIC_TEST), Functional Image (DIAGNOSTIC_TEST), Digit Span subtest (BEHAVIORAL), Trail Making Test (Parts A & B) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03508765?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.